Pine Labs (PINELABS)

FairStock Score: 49/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Strong top-line momentum: sales growth of 23.71% and 5-year revenue CAGR of 27.69%.
• Latest quarter turned a net profit of ₹42 Cr, a possible inflection point.
• Low leverage with Debt/Equity at only 0.23.
• Piotroski F-Score of 6/9 suggests no severe financial deterioration.

Concerns

• Free cash flow is deeply negative at ₹-436 Cr; growth is consuming cash.
• Zero promoter holding and zero dividend raise governance and minority-alignment concerns.
• ROCE is -0.49%, ROE is N/A, and P/E is 0.00 — profitability/returns are not yet validated.
• P/B of 5.96 against book value of ₹32.98 implies a rich price for unproven earnings; FairStock Score is 31/100 (RISKY).

AI Analysis

Let's look at Pine Labs as an owner, not a trader. In many ways this is a business I want to like: 23.71% sales growth, a 27.69% five-year revenue CAGR, and latest quarter revenue of ₹744 Cr. But I don't invest in what a company will become; I invest in what the numbers prove. Here the proof is thin. Return on capital is negative at -0.49%, ROE is not available, and the P/E is zero because earnings have not been meaningful. A small quarterly profit of ₹42 Cr is encouraging, but profit growth of 311% from a tiny base tells me more about the base than the quality. Free cash flow is minus ₹436 Cr. That means growth is eating cash rather than generating it. In my experience, high growth and negative free cash flow is a dangerous combination unless the business has a structural moat strong enough to eventually dictate pricing. Debt/equity is low at 0.23, so the balance sheet is not reckless, but book value is only ₹32.98 against a price of ₹196.70. I'm paying 5.96 times book for a business that isn't yet earning a return on that book. Also, promoter holding is zero. I want owners whose interests align with mine. That absence, along with no dividend, leaves nothing returned to minority holders. The fair stock score of 31/100 puts a heavy weight on uncertainty. Pine Labs is a fast grower, no question, but a fast grower that is not yet a wealth creator. The numbers show revenue momentum, not proof of competitive durability. I'd keep it on the watchlist and wait for evidence of free cash flow and consistent returns on capital before putting my money at risk.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer